New ultrasound imaging for pancreas and thyroid
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests new ultrasound methods to better see the pancreas and thyroid. It includes people at high risk for pancreatic cancer, those with pancreatic cancer, those with a thyroid nodule, and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You may join if you are at high risk for pancreatic cancer due to family history or genetic mutations, or if you have pancreatic cancer or a thyroid nodule that needs a biopsy.
- You must be at least 18 years old (some groups have higher age minimums based on condition).
- You cannot be pregnant or nursing.
- If you are in the high-risk group, you need to meet specific family history or genetic criteria (like having two affected relatives or a gene mutation).
- You must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
This study uses a special ultrasound method called contrast-enhanced ultrasound (CEUS) to see if it can improve accuracy of diagnosing thyroid cancer. If you have a thyroid nodule and have had certain tests, this trial may help doctors better understand your condition.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
This Phase 3 study tests a structured plan for checking the pancreas early in people with a higher-than-usual risk of pancreatic cancer. The goal is to find changes sooner, when treatment may be easier.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.